MedTrace Logo

Clinical Efficacy of the Product in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP) Subjects

NCT06822335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2025-02-12

No results posted yet for this study

Summary

Double-blind, randomized, clinical study is designed to evaluate the efficacy of Niacinamide A in the management of facial Post Inflammatory Hyper Pigmentation (PIHP) in healthy female and male subjects with moderate to severe PIHP due to acne, mild acne and (≤4) inflammatory lesions, its impact on skin lightening effect and lastly any associated benefits on skin quality.

Conditions

  • Acne
  • Post-inflammatory Hyperpigmentation

Sponsors & Collaborators

  • Cosmetique Active International

    lead INDUSTRY

Principal Investigators

  • Gitanjali Gitanjali, MBBS, DDV · CIDP Ltée

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2023-08-07
Completion
2023-08-08

Countries

  • Mauritius

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06822335 on ClinicalTrials.gov